Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 885 of 1,261
  1. US 8378107

    Heteroaryl antagonists of prostaglandin D2 receptors

    Panmira Pharmaceuticals, LLC · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted
  2. US 8377966

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted
  3. US 8377637

    MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer using miR-17-3P

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted
  4. US 8377444

    Therapeutic agent or preventive agent for osteoarthritis

    AXIS · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted
  5. US 8377450

    Clone of Newcastle disease virus, its manufacture and its application in the medical treatment of cancer

    United Cancer Research Institute · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted
  6. US 2013041307

    APPLICATION OF BETA-FUNCTIONALIZED DIHYDROXY-CHLORINS FOR PDT

    CERAMOPTEC IND INC [DE] · Granted Feb 14, 2013 · Expires Feb 9, 2033

    granted
  7. EP 2555769

    VERFAHREN ZUR BEHANDLUNG VON VIRALEN ATEMWEGSINFEKTIONEN

    CELGENE CORP [US] · Granted Feb 13, 2013 · Expires Feb 8, 2033

    granted
  8. US 8372850

    Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Feb 12, 2013 · Expires Feb 7, 2033

    granted
  9. US 8372872

    Methods for concomitant treatment of theophylline and febuxostat

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Feb 12, 2013 · Expires Feb 7, 2033

    granted
  10. US 8372860

    Carboline derivatives useful in the inhibition of angiogenesis

    PTC THERAPEUTICS, INC. · Granted Feb 12, 2013 · Expires Feb 7, 2033

    granted
  11. US 8372846

    Co-crystals and pharmaceutical compositions comprising the same

    Vertex Pharmaceuticals Incorporated · Granted Feb 12, 2013 · Expires Feb 7, 2033

    granted
  12. US 8372835

    Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Feb 12, 2013 · Expires Feb 7, 2033

    granted
  13. US 8372826

    Estriol therapy for multiple sclerosis and other autoimmune diseases

    The Regents of the University of California · Granted Feb 12, 2013 · Expires Feb 7, 2033

    granted
  14. US 8372812

    Phospholipid and protein tablets

    Aker Biomarine AS · Granted Feb 12, 2013 · Expires Feb 7, 2033

    granted
  15. US 8372802

    Fluorinated macrocyclic compounds as hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Feb 12, 2013 · Expires Feb 7, 2033

    granted
  16. US 8372843

    Quinolines useful as modulators of ION channels

    Vertex Pharmaceuticals Incorporated · Granted Feb 12, 2013 · Expires Feb 7, 2033

    granted
  17. US 8372422

    Hydroxyapatite-targeting poly(ethylene glycol) and related polymers

    Nektar Therapeutics · Granted Feb 12, 2013 · Expires Feb 7, 2033

    granted
  18. US 8372435

    Modular monolayer coatings for selective attachment of nanoparticles to biomolecules

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Feb 12, 2013 · Expires Feb 7, 2033

    granted
  19. US 8372415

    Wet granulation using a water sequestering agent

    Rigel Pharmaceuticals, Inc. · Granted Feb 12, 2013 · Expires Feb 7, 2033

    granted
  20. US 8372380

    In vivo imaging of sulfotransferases

    The Regents of the University of California · Granted Feb 12, 2013 · Expires Feb 7, 2033

    granted
  21. US 8372984

    Dual-acting oxazole antihypertensive agents

    Theravance, Inc. · Granted Feb 12, 2013 · Expires Feb 7, 2033

    granted
  22. US 8372979

    Process for the production of high-purity 2,4′-dimethyl-3-piperidino-propiophenone (tolperisone), pharmaceutical compositions that contain the latter, as well as active ingredient formulations that contain tolperisone

    SANOCHEMIA PHARMAZEUTIKA AG · Granted Feb 12, 2013 · Expires Feb 7, 2033

    granted
  23. US 8372883

    Methods of using cycloalkylmethylamines

    REVIVA PHARMACEUTICALS, INC. · Granted Feb 12, 2013 · Expires Feb 7, 2033

    granted
  24. US 8372873

    Inhibitors of serine proteases

    Vertex Pharmaceuticals Incorporated · Granted Feb 12, 2013 · Expires Feb 7, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.